PRKN and pulmonary fibrosis: Enhanced lung fibrosis in BLM-treated PARK2 KO mouse was effectively attenuated by treatment with PFD, which was comparable to levels seen in BLM-treated, PFD-treated wild type mice (Fig. 5a, b).